调节性T细胞在重症肌无力研究中的进展  

Regulatory T cells and its research progress in myasthenia gravis

作　　者：徐朋亮 朱勇俊[1] 宋阳[1] 陈志明[1] 

机构地区：[1]复旦大学附属华山医院心胸外科,上海200040

出　　处：《中华胸部外科电子杂志》2016年第4期234-238,共5页CHINESE JOURNAL OF THORACIC SURGERY：Electronic Edition

摘　　要：重症肌无力(MG)为一种由乙酰胆碱受体的抗体介导的、具有T细胞依赖性的自身免疫性疾病。目前研究发现,调节性T细胞(Treg)功能异常在多种自身免疫性疾病包括重症肌无力的发生、发展起着重要作用。文章重点介绍了Treg细胞的特点及其在重症肌无力作用机制方面的进展,旨在能够发现一种对重症肌无力和其他自身免疫性疾病有效的以异常T细胞为基础的治疗方法。Myasthenia gravis （MG） is an antibody-mediated, T cell-dependent autoimmune disease. Recent researches have revealed that the dysfunction in the Regulatory T cell （Treg） compartment is involved in the etiology and pathogenesis of a variety of autoimmune diseases, including MG. This paper focuses on the characteristics of Treg and its mechanism of action on MG. It is hoped to pave a way that will restore self-tolerance in MG and other autoimmune diseases towards the Treg-based treatment modalities.

关 键 词：重症肌无力 调节性丁细胞 FOXP3 

分 类 号：R746.1[医药卫生—神经病学与精神病学]